Donaldson Company, Inc. (DNZ.F)
| Previous close | 68.50 |
| Open | 67.50 |
| Bid | 67.00 x 19800 |
| Ask | 68.00 x 19400 |
| Day's range | 67.50 - 67.50 |
| 52-week range | 53.00 - 69.50 |
| Volume | |
| Avg. volume | 2 |
| Market cap | 8.125B |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | 24.02 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.92 (1.35%) |
| Ex-dividend date | 09 Feb 2024 |
| 1y target est | N/A |
- Business Wire
Donaldson Employees Recognized at May 13, 2024, Patent Recipient and Inventor Awards
MINNEAPOLIS, May 14, 2024--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, celebrated its 2024 patent recipients and Inventor Award winners. One hundred individuals were recognized this year for their valuable contributions to Donaldson’s innovative leadership in technology-led filtration products and solutions.
- Business Wire
Donaldson and PolyPeptide Partner to Improve Sustainability in Peptide Manufacturing with Solvent Recovery Technology
MINNEAPOLIS & TORRANCE, Calif., May 13, 2024--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and PolyPeptide Group AG (SIX: PPGN), a global leader in peptide manufacturing, today announced their collaboration on the development of a production scale solvent recovery system for use in peptide purification. Peptides are used as the active pharmaceutical ingredient (API) in therapeutic areas, which continue to br
- Business Wire
Donaldson Announces Integrated Lentiviral Vector Manufacturing Platform Development
MINNEAPOLIS, May 08, 2024--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, announced its Isolere Bio (Isolere) and Univercells Technologies businesses are developing an integrated upstream and downstream platform for viral vector manufacturing. The first phase will focus on lentivirus (LV) manufacturing, concentrating on improving recoveries with a scalable process while keeping the manufacturing footprint small.
